Risk factors

Shuttle Pharmaceuticals Holdings (SHPH) risk factors

Item 1A of every Shuttle Pharmaceuticals Holdings, Inc. 10-K on file, and what changed from one year to the next.

Open SHPH in Gloomberb →
  • FY2025 10-K risk factors

    17 risks, 4 new, 36 dropped, 4 reworded since the prior year. Shuttle Pharmaceuticals added risks related to its Molecule.ai acquisition and ongoing Nasdaq listing compliance issues involving stockholders equity and bid price. The company dropped 36 general development and clinical trial risks.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    49 risks. Shuttle Pharmaceuticals has no commercial revenue and depends on developing early-stage candidates like Ropidoxuridine and HDAC inhibitors.

    Filed Feb 26, 2025